• 1. Crystal structures, red-shifted luminescence and iodide-anion recognition properties of four novel D–A type Zn(ii) complexes
  Jian-Biao Song,Pengfei Wang,Li Yan,Liang Hao,Maroof Ahmad Khan,Gui-lei Liu,Hui Li Dalton Trans. 2020 49 4358
• 2. Benzimidazole functionalized covalent triazine frameworks for CO2 capture
  Liming Tao,Fang Niu,Chao Wang,Jingang Liu,Tingmei Wang,Qihua Wang J. Mater. Chem. A 2016 4 11812
• 3. Amide-bridged conjugated organic polymers: efficient metal-free catalysts for visible-light-driven CO2 reduction with H2O to CO
  Fan Wen,Fengtao Zhang,Zhen Wang,Xiaoxiao Yu,Guipeng Ji,Dongyang Li,Shengrui Tong,Yingbin Wang,Buxing Han,Zhimin Liu Chem. Sci. 2021 12 11548
• 4. Novel yellow thermally activated delayed fluorescence emitters for highly efficient full-TADF WOLEDs with low driving voltages and remarkable color stability
  Tingting Huang,Di Liu,Deli Li,Wenfeng Jiang,Jingyang Jiang New J. Chem. 2019 43 13339
• 5. A quinoxalinophenazinedione covalent triazine framework for boosted high-performance aqueous zinc-ion batteries
  Yiyun Wang,Xinlei Wang,Jian Tang,Weihua Tang J. Mater. Chem. A 2022 10 13868

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzonitriles
• Solvents and Organic Chemicals Organic Compounds cyanides/Cyanides

Recent Advances in the Study of 3,4-Diaminobenzonitrile (CAS: 17626-40-3) and Its Applications in Chemical Biology and Pharmaceutical Research

3,4-Diaminobenzonitrile (CAS: 17626-40-3) is a chemical compound of significant interest in the fields of chemical biology and pharmaceutical research. Its unique structural properties, characterized by the presence of two amino groups and a nitrile functionality, make it a versatile intermediate in the synthesis of various bioactive molecules. Recent studies have explored its potential applications in drug discovery, material science, and as a precursor for the development of novel therapeutic agents. This research brief aims to summarize the latest findings related to 3,4-Diaminobenzonitrile, focusing on its synthesis, biological activity, and emerging applications.

One of the key areas of research involving 3,4-Diaminobenzonitrile is its role in the synthesis of heterocyclic compounds. A study published in the Journal of Medicinal Chemistry (2023) demonstrated its utility as a building block for the preparation of quinoxaline derivatives, which exhibit potent antimicrobial and anticancer activities. The researchers employed a novel catalytic method to achieve high yields and selectivity, highlighting the compound's potential in scalable pharmaceutical production. Additionally, the study revealed that the nitrile group in 3,4-Diaminobenzonitrile can be further functionalized to introduce diverse pharmacophores, thereby expanding its applicability in drug design.

Another significant development is the investigation of 3,4-Diaminobenzonitrile as a corrosion inhibitor. A recent report in ACS Applied Materials & Interfaces (2024) showcased its effectiveness in protecting metal surfaces in aggressive environments. The study utilized electrochemical impedance spectroscopy and surface analysis techniques to elucidate the mechanism of action, which involves the formation of a protective film on the metal surface. These findings open new avenues for the use of 3,4-Diaminobenzonitrile in industrial applications, particularly in the oil and gas sector where corrosion resistance is critical.

In the realm of material science, 3,4-Diaminobenzonitrile has been explored as a precursor for the synthesis of conductive polymers. A research team at MIT (2023) reported the successful polymerization of 3,4-Diaminobenzonitrile to produce polyaniline-like structures with enhanced electrical conductivity and thermal stability. These polymers hold promise for use in flexible electronics, sensors, and energy storage devices. The study also highlighted the compound's potential for creating hybrid materials with unique optoelectronic properties, further broadening its scope of application.

Despite these advancements, challenges remain in the large-scale production and purification of 3,4-Diaminobenzonitrile. A recent review in Chemical Reviews (2024) emphasized the need for greener synthetic routes and more efficient purification techniques to minimize environmental impact and reduce costs. The review also called for further studies to explore the compound's toxicity profile and long-term stability, which are crucial for its adoption in pharmaceutical formulations. Addressing these challenges will be essential for unlocking the full potential of 3,4-Diaminobenzonitrile in various industrial and biomedical applications.

In conclusion, 3,4-Diaminobenzonitrile (CAS: 17626-40-3) continues to be a compound of great interest in chemical biology and pharmaceutical research. Its versatility as a synthetic intermediate, combined with its emerging applications in material science and corrosion inhibition, underscores its importance in modern chemistry. Future research should focus on optimizing its synthesis, exploring new functionalization strategies, and evaluating its safety and efficacy in diverse applications. The ongoing studies on this compound are expected to yield significant contributions to the advancement of science and technology.

• 89332-00-3(Benzonitrile, 4-amino-, monohydrobromide)
• 468741-03-9( )
• 33786-93-5(Benzonitrile,3,5-diamino-)
• 802288-13-7(Benzonitrile,2,3,5,6-tetraamino-)
• 79780-61-3(1,4-Benzenedicarbonitrile, 2,3-diamino-)
• 129365-93-1(4,5-diaminobenzene-1,2-dicarbonitrile)
• 73629-43-3(2,3-Diaminobenzonitrile)
• 873-74-5(4-Aminobenzonitrile)
• 139957-01-0(Aminylium, (3-cyanophenyl)-)
• 186551-97-3(3-Amino-5-methylbenzonitrile)